Michigan State University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Michigan State University sits in the top decile of US sponsors by registered trial count (#217 of 15,742 sponsors by registered trial count).
Michigan State University: 120 sponsored US clinical trials, 24 recruiting.
Michigan State University sponsors 120 registered US clinical trials on ClinicalTrials.gov, 24 of them currently recruiting, and 79 completed. 4 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Vaccine-Preventable Diseases, with 2 trials.
Top-decile sponsor footprint
Michigan State University ranks in the top decile of sponsors by registered trial count (#217 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
79 of 86 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
120 total, page 3 of 3
Mindfulness Therapy for Individuals With Lung Cancer
NCT01565980
Intra-abdominal Pressure Monitoring in Patients With Open Abdomen Undergoing Early Closure
NCT02107781
A Comparison of Propofol Versus Midazolam to Sedate Critically Brain Injury; Measurement of Cytokine Response and Assessment of Function
NCT01712477
Saw Palmetto: Symptom Management for Men During Radiation Therapy
NCT01585246
Girls on the Move Intervention to Increase Physical Activity Among Middle School Girls
NCT01503333
Osteopathic Manipulative Medicine and Kinetics
NCT01376687
Kin KeeperSM: Reducing Disparities Through Cancer Literacy and Screening
NCT01910350
Healthy Babies Through Infant Centered Feeding
NCT01816516
Interexaminer Reliability, Outcomes for Manipulation of Cervical Dysfunction, 3-D Kinematics
NCT01186718
Project Fit:a School- and Community-based Obesity Intervention
NCT01385046
Middle School Physical Activity Intervention for Girls
NCT01351649
Objective Kinematic Correlates of Palpatory Diagnosis
NCT00728247
Usefulness of Home Pregnancy Testing
NCT00390754
Urinary Bactericidal Activity of 4 Doses of Levofloxacin Against Fluoroquinolone-Resistant E. Coli
NCT00376376
Reflexology: An Intervention for Advanced Breast Cancer
NCT01577420
Automated Telephone Monitoring for Symptom Management
NCT00799084
Pain and Fatigue Study
NCT00006253
Translating Research: Patient Decision Support/Coaching
NCT00416026
The Effect of Osteopathic Manipulative Treatment on Recovery of Coronary Bypass Patients
NCT00504179
Medicaid Enhanced Prenatal/Postnatal Services Using a Nurse-Community Health Worker Team
NCT00536159
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 7 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the Michigan State University pipeline
24 recruiting of 120 indexed (20% open); 79 completed (66%).
Phase mix: 4 late (III/IV) vs 14 early (I/II) (early-phase heavy).
Top condition: Vaccine-Preventable Diseases (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Michigan State University: open-pipeline peers nationwide
Peers matched on 120 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Michigan State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 120 trials (± recruiting share)
- Children's Hospital Los Angeles · 119 trials · 29% recruiting
- Jaeb Center for Health Research · 119 trials · 14% recruiting
- Medtronic - MITG · 119 trials · 4% recruiting
- West Virginia University · 122 trials · 18% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
Related
What to do with this Michigan State University page
120 registered trials is a research-attention snapshot, not an endorsement of Michigan State University or any single study.
- 24 of Michigan State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Vaccine-Preventable Diseases is the condition Michigan State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Vaccine-Preventable Diseases trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Michigan State University pipeline card: 120 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.